Bespoke Extracts, Inc. (BSPK) Cash & Equivalents (2011 - 2025)

Bespoke Extracts has reported Cash & Equivalents for 15 years, with the latest figure at $16743.0 in Q3 2025.

• Quarterly Cash & Equivalents fell 21.93% year-over-year to $16743.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $16743.0 (down 21.93% YoY) and the FY2024 annual result came in at $60305.0, up 812.74% from the prior year.
• Cash & Equivalents advanced to $16743.0 in Q3 2025 per BSPK's latest filing, from $1363.0 in the prior quarter.
• Over five years, Cash & Equivalents peaked at $501560.0 in Q1 2021 and troughed at $1363.0 in Q2 2025.
• A 5-year average of $52151.0 and a median of $19094.0 in 2024 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 27522.92% in 2021, down 97.56% in 2021.
• Over 5 years, Cash & Equivalents stood at $6295.0 in 2021, then soared by 288.13% to $24433.0 in 2022, then slumped by 72.96% to $6607.0 in 2023, then surged by 812.74% to $60305.0 in 2024, then sank by 72.24% to $16743.0 in 2025.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $16743.0, $1363.0, and $30365.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.